Study of fetomaternal outcome in HIV positive pregnant female at a tertiary health center in South Gujarat

Authors

  • Jigisha Chauhan Department of Obstetrics and Gynaecology, SMIMER, Surat, Gujarat, India
  • Shraddha Agarwal Department of Obstetrics and Gynaecology, SMIMER, Surat, Gujarat, India
  • Riya Kansal Government Medical College, Surat, Gujarat, India
  • Zarana Patel Department of Obstetrics and Gynaecology, SMIMER, Surat, Gujarat, India
  • Krunal Patel District Hospital, Chikli, Navsari, Gujarat, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20233635

Keywords:

HIV positive, PPTCT, CD4 count, ART

Abstract

Background: Prenatal identification of HIV infected women is crucial for delivery and optimal care to both mother and fetus. Prevention of parent-to-child transmission has been the major tool to identify HIV-infected pregnant women by voluntary counselling and testing for HIV and provide antiretroviral drug prophylaxis to them during delivery and then to their newborn infants. Aim and objective was to study the fetomaternal outcome of HIV Positive antenatal patients.

Methods: This was simple descriptive study which was conducted between January 2017 to June 2019 with 18 months follow-up suggestive of 40 patients were having HIV positive among 9015 deliveries. Thorough examination, investigations and treatment given according to NACO guidelines and fetomaternal outcome were noted in all cases.

Results: In present study, prevalence of HIV Positive pregnant women was 0.44%. Out of 40 patients, 5 patients were diagnosed with TB. 55% cases were diagnosed with HIV during ANC examination. 22 (55%) patients were having CD4 count >500 and 1 (2.5%) patient having low CD4 count <200. 32 (80%) patients delivered vaginally and 8 (20%) underwent LSCS. 8 (20%) of babies were admitted to NICU, 3 expired and 37 babies tested negative, 3 losses to follow-up and 34 tested negatives at 18months.

Conclusions: Mother-to-child transmission is the predominant way children become infected with human immunodeficiency virus worldwide. Good antenatal care and multidisciplinary approach to HIV-infected women can have good pregnancy outcome and early prophylaxis to the baby leads to decreased incidence of disease in the community.

 

References

Updated Guidelines for Prevention of Parent to Child Transmission (PPTCT) of HIV using Multi-Drug Anti-retroviral regimen in India. Available at: https://naco.gov.in/sites/default/files/National_Guidelines_for_PPTCT.pdf. Accessed on 20 February 2023.

Newell M-L, Gray G, Bryson YJ. Prevention of mother-to child transmission of HIV-1 transmission. AIDS. 1997;11:S165-72.

Boyer PJ, Dillon M, Navaie M, Deveikis A, Keller M, O'Rourke S, Bryson YJ. Factors predictive of maternal-fetal transmission of HIV-1. Preliminary analysis of zidovudine given during pregnancy and/or delivery. JAMA. 1994;271(24):1925-30.

Temmerman M, Plummer FA, Mirza NB, Ndinya-Achola JO, Wamola IA, Nagelkerke N, Brunham RC, Piot P. Infection with HIV as a risk factor for adverse obstetrical outcome. AIDS. 1990;4(11):1087-93.

Feldblum PJ, Morrison CS, Roddy RE, Cates W Jr. The effectiveness of barrier methods of contraception in preventing the spread of HIV. AIDS. 1995;9:S85-93.

Global HIV/AIDS response. Available at: https://www.who.int. Accessed on 20 February 2023.

Dunn DT, Newell ML, Ades AE, Peckham CS. Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet. 1992;340(8819):585-8.

Izzo I, Forleo MA, Casari S, Quiros-Roldan E, Magoni M, Carosi G, et al. Maternal characteristics during pregnancy and risk factors for positive HIV RNA at delivery: a singlecohort observational study (Brescia, Northern Italy). BMC Public Health. 2011;11(1):124.

Updated guidelines of Prevention of Parent to Child Transmission (PPTCT) of HIV using Multi Drug Anti-retroviral Regimen in India. Available at: https://naco.gov.in/sites/default/files/National_Guidelines_for_PPTCT.pdf. Accessed on 20 February 2023.

Tubiana WJ, Le Chenadec J, Blanche S, Teglas JP, Dollfus C. Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort. AIDS. 2008;22(2):289-99.

Hirsch HH, Kaufmann G, Sendi P, Battegay M. Immune reconstitution in HIV-infected patients. Clin Infect Dis. 2004;38(8):1159-66.

Price AJ, Kayange M, Zaba B, Chimbandrira FM, Jahn A, Chirwa Z, et al. Uptake of prevention of mother-to-child-transmission using Option B+ in northern rural Malawi: a retrospective cohort study. Sex Transmit Infect. 2014;12:23-9.

Townsend CL, Byrne L, Cortina-Borja M, Thorne C, de Ruiter A, Lyall H, et al. Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000-2011. AIDS. 2014;28(7): 1049-57.

Mandelbrot L, Le Chenadec J, Berrebi A, Bongain A, Bénifla JL, Delfraissy JF, et al. Perinatal HIV-1 transmission: interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort. JAMA. 1998;280(1):55-60.

Poteat T, Ackerman B, Diouf D, Ceesay N, Mothopeng T, Odette KZ, et al. HIV prevalence and behavioral and psychosocial factors among transgender women and cisgender men who have sex with men in 8 African countries: A cross-sectional analysis. PLoS Med. 2017;14(11):e100.

Downloads

Published

2023-11-28

Issue

Section

Original Research Articles